Bui Van Phi, left, chairperson of the Vietnamese Association in Gunma and vice chairperson Shohei Sato are seen in the city of Maebashi, Gunma Prefecture, on Dec. 14, 2023. (Mainichi/Tetsuya Shoji) ...
Japan's Oncolys BioPharma has started a U.S.-based Phase I trial of cancer drug candidate OBP-801 licensed from Astellas Pharma in 2009. The company listed on the Tokyo Stock Exchange Mothers Market ...
In something of a surprise move, Japan's NanoCarrier submitted a Phase I application to the Pharmaceuticals and Medical Devices Agency for oncology candidate NC-6004, Nanoplatin, on June 9. In January ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results